Prestige Consumer Healthcare Inc (PBH) Shares Fall 3.4% -- What GF Score of 70 Tells InvestorsGuruFocus · 1 day ago
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?Zacks Investment Research · Oct 15, 2026
Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings ResultsGlobeNewsWire · Oct 14, 2026
Amylyx's Avexitide Phase III Win Sets Up FDA Filing for PBH TreatmentMarketBeat · Oct 3, 2026
Best Value Stocks to Buy for October 1stZacks Investment Research · Oct 1, 2026
PBH vs. NEOG: Which Stock Is the Better Value Option?Zacks Investment Research · Sep 30, 2026Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine).
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | $0.89 | $0.98 | Beat |
| May 13, 2026 | $1.39 | $1.23 | Miss |
| Feb 5, 2026 | $1.16 | $1.14 | Miss |
| Nov 6, 2025 | $0.97 | $1.07 | Beat |
| Aug 7, 2025 | $1.01 | $0.95 | Miss |
| May 8, 2025 | $1.30 | $1.32 | Beat |